The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmiths Group Regulatory News (SMIN)

Share Price Information for Smiths Group (SMIN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,740.00
Bid: 1,740.00
Ask: 1,741.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.057%)
Open: 1,736.00
High: 1,740.00
Low: 1,730.00
Prev. Close: 1,740.00
SMIN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Disposal

1 Jun 2017 14:00

RNS Number : 8693G
Smiths Group PLC
01 June 2017
 

 

News Release

London, 1 June 2017

For immediate release

 

 

Smiths Group agrees to sell Morpho Detection's former trace business

Smiths Group plc ("Smiths Group") today announces that it has entered into a binding agreement with OSI Systems, Inc to sell the explosive trace detection business formerly owned by Morpho Detection (the "Trace Business") for an enterprise value of $75.5 million.

In connection with its acquisition of Morpho Detection from Safran, Smiths Group had made commitments to the European Commission ("EC") and the Department of Justice ("DOJ") to sell the Trace Business. The sale is conditional upon regulatory approval in Portugal and the approval by the EC and DOJ of OSI Systems, Inc as a suitable purchaser. Completion is expected in mid-2017.

 

ENDS

 

Contact details

Marion Le Bot, Smiths Group

+44 (0)20 7004 1672

+44 (0)75 8315 4386

marion.lebot@smiths.com 

 

Media enquiries

Andrew Lorenz, FTI Consulting

+44 (0)203 727 1323

+44 (0)777 564 1807

smiths@fticonsulting.com

 

Deborah Scott, FTI Consulting

+44 (0)203 727 1459

+44 (0)797 953 7449

smiths@fticonsulting.com

 

 

Smiths Group is a global technology company listed on the London Stock Exchange (SMIN) and operates a sponsored level one ADR programme (SMGZY). A world leader in the practical application of advanced technologies, Smiths Group delivers products and services for the threat & contraband detection, medical devices, energy and communications markets worldwide. Smiths Group employs more than 22,000 people in over 50 countries. For more information visit www.smiths.com.

 

 

Disclaimer

This announcement contains certain statements that are forward-looking statements. They appear in a number of places throughout this announcement and include statements regarding our intentions, beliefs or current expectations and those of our officers, directors and employees concerning, amongst other things, our results of operations, financial condition, liquidity, prospects, growth, strategies and the business we operate. By their nature, these statements involve uncertainty since future events and circumstances can cause results and developments to differ materially from those anticipated. The forward-looking statements reflect knowledge and information available at the date of preparation of this announcement and, unless otherwise required by applicable law, Smiths undertakes no obligation to update or revise these forward-looking statements. Nothing in this document should be construed as a profit forecast.

 

No statement in this announcement is intended to be a profit forecast and no statement in this announcement should be interpreted to mean that earnings per Smiths ordinary share for the current or future financial years would necessarily match or exceed the historical published earnings per Smiths ordinary share. Prices and values of, and income from, shares may go down as well as up and an investor may not get back the amount invested. It should be noted that past performance is no guide to future performance. Persons needing advice should consult an independent financial adviser.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISLLFSIRIILIID
Date   Source Headline
22nd Mar 20197:00 amRNSHalf-year Report
28th Feb 20195:15 pmRNSTotal Voting Rights
27th Feb 201911:15 amRNSHolding(s) in Company
1st Feb 201910:24 amRNSDirector/PDMR Shareholding
1st Feb 20198:41 amRNSTotal Voting Rights
2nd Jan 201910:30 amRNSTotal Voting Rights
30th Nov 20185:00 pmRNSTotal Voting Rights
28th Nov 20185:00 pmRNSHolding(s) in Company
14th Nov 20181:36 pmRNSResult of AGM
14th Nov 20187:00 amRNSSmiths Group intention to separate Smiths Medical
14th Nov 20187:00 amRNSTrading Statement
1st Nov 20184:15 pmRNSBlock listing Interim Review
1st Nov 201812:00 pmRNSDirector/PDMR Shareholding
1st Nov 201812:00 pmRNSDirector/PDMR Shareholding
31st Oct 20185:15 pmRNSTotal Voting Rights
26th Oct 20187:00 amRNSSmiths - Appointment of Joint Corporate Broker
19th Oct 20188:27 amRNSDirector/PDMR Shareholding
12th Oct 20189:40 amRNSAnnual Financial Report
10th Oct 201810:15 amRNSDirector/PDMR Shareholding
4th Oct 20183:30 pmRNSHolding(s) in Company
4th Oct 20187:00 amRNSAcquisition
1st Oct 20189:30 amRNSTotal Voting Rights
27th Sep 20182:15 pmRNSDirector/PDMR Shareholding
26th Sep 20181:30 pmRNSDirector/PDMR Shareholding
21st Sep 20187:05 amRNSSmiths Group sells Medical water bottling business
21st Sep 20187:00 amRNSFinal Results
13th Sep 201812:45 pmRNSStatement re Smiths Medical
3rd Sep 20183:00 pmRNSTotal Voting Rights
3rd Aug 20182:51 pmRNSRedemption of Notes
1st Aug 201811:45 amRNSDirector/PDMR Shareholding
31st Jul 20185:15 pmRNSTotal Voting Rights
26th Jul 201810:24 amRNSDirectorate Change
18th Jul 20187:00 amRNSSmiths Group pre-close trading update
2nd Jul 20189:00 amRNSTotal Voting Rights
1st Jun 201811:00 amRNSHolding(s) in Company
31st May 20185:15 pmRNSTotal Voting Rights
29th May 20187:00 amRNSStatement regarding Smiths Medical
22nd May 20184:07 pmRNSDirectorate Change
15th May 20185:39 pmRNSHolding(s) in Company
1st May 201812:00 pmRNSDirector/PDMR Shareholding
1st May 20189:30 amRNSBlock listing Interim Review
30th Apr 20185:15 pmRNSTotal Voting Rights
27th Apr 20181:31 pmRNSHolding(s) in Company
4th Apr 20182:51 pmRNSDirector/PDMR Shareholding
4th Apr 20182:48 pmRNSDirector/PDMR Shareholding
23rd Mar 20187:00 amRNSHalf-year Report
28th Feb 20185:05 pmRNSTotal Voting Rights
26th Feb 20185:30 pmRNSHolding(s) in Company
1st Feb 201810:30 amRNSDirector/PDMR Shareholding
31st Jan 20185:02 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.